Management of Secondary Hemophagocytosis Lymphohistiocytosis with Severe Liver Dysfunction
Abstract
Introduction:Hemophagocytosis Lymphohistiocytosis (HLH) is a syndrome of inappropriate hyperimmune response.
Presentation of Case:We present a case of secondary HLH associated with systemic lupus erythematous (SLE) and liver dysfunction.
Conclusion:This case report focuses on the diagnostic dilemmas with HLH and an individualized treatment approach to the patient.
Keywords
Full Text:
PDFReferences
La Rosee P. Treatment of hemophagocytic lymphohistiocytosis in adults. Hematology Am Soc Hematol Educ Program. 2015, 2015:190-196
Birndt S, Schenk T, Brunkhorst FM, Maschmeyer G, Rothmann F, Weber T, Müller M, Panse JP, Schroers R, Braess J, Frickhofen N, Janka G, Lehmberg K, Hochhaus A, Ernst T, La Rosée P. Hemophagocytic lymphohistiocytosis in adults (ahlh): Results from the german hlh registry. Blood. 2016, 128:2523-2523
Schulert GS, Grom AA. Macrophage activation syndrome and cytokine-directed therapies. Best Pract Res Clin Rheumatol. 2014, 28:277-292
Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G. Hlh-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007, 48:124-131
Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, Coppo P, Hejblum G. Development and validation of the hscore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014, 66:2613-2620
Ravelli A. Toward an understanding of the long-term outcome of juvenile idiopathic arthritis. Clin Exp Rheumatol. 2004, 22:271-275
Davi S, Consolaro A, Guseinova D, Pistorio A, Ruperto N, Martini A, Cron RQ, Ravelli A, Group MASS. An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol. 2011, 38:764-768
Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How i treat hemophagocytic lymphohistiocytosis. Blood. 2011, 118:4041-4052
Kleynberg RL, Schiller GJ. Secondary hemophagocytic lymphohistiocytosis in adults: An update on diagnosis and therapy. Clin Adv Hematol Oncol. 2012, 10:726-732
Weitzman S. Approach to hemophagocytic syndromes. Hematology Am Soc Hematol Educ Program. 2011, 2011:178-183
Henter JI, Samuelsson-Horne A, Arico M, Egeler RM, Elinder G, Filipovich AH, Gadner H, Imashuku S, Komp D, Ladisch S, Webb D, Janka G, Histocyte S. Treatment of hemophagocytic lymphohistiocytosis with hlh-94 immunochemotherapy and bone marrow transplantation. Blood. 2002, 100:2367-2373
Trottestam H, Horne A, Arico M, Egeler RM, Filipovich AH, Gadner H, Imashuku S, Ladisch S, Webb D, Janka G, Henter JI, Histiocyte S. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: Long-term results of the hlh-94 treatment protocol. Blood. 2011, 118:4577-4584
Marsh RA, Allen CE, McClain KL, Weinstein JL, Kanter J, Skiles J, Lee ND, Khan SP, Lawrence J, Mo JQ, Bleesing JJ, Filipovich AH, Jordan MB. Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab. Pediatr Blood Cancer. 2013, 60:101-109
Bleesing J, Prada A, Siegel DM, Villanueva J, Olson J, Ilowite NT, Brunner HI, Griffin T, Graham TB, Sherry DD, Passo MH, Ramanan AV, Filipovich A, Grom AA. The diagnostic significance of soluble cd163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum. 2007, 56:965-971
Refbacks
- There are currently no refbacks.
